← Open Payments lookup

MARILYN MARTIN: Open Payments

NPI 1821014507 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,694 in 52 payments from 16 companies in 2025. Trend: 2023 $2,197 · 2024 $1,958 · 2025 $1,694

Food & beverage: $1,694
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$315
Vanda Pharmaceuticals Inc.6$264
Janssen Pharmaceuticals, Inc4$186
Otsuka America Pharmaceutical, Inc.6$144
Axsome Therapeutics, Inc.3$143
Teva Pharmaceuticals USA, Inc.2$131
Neurocrine BioSciences, Inc.4$114
Lundbeck LLC5$109
Alkermes, Inc.4$88
Orexo US, Inc.3$51

Products named: CAPLYTA, REXULTI, SPRAVATO, HETLIOZ, Auvelity, AUSTEDO XR, FANAPT, INGREZZA.

Industry payments across MD — which companies pay providers there.